Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 3/2005

01-04-2005 | Case Report

Plasmacytoma of the Urinary Bladder in a Renal Transplant Recipient

Authors: Ryoichi Takahashi, Sonoko Nakano, Kyoko Namura, Noriko Yamada, Ryo Uchida, Shin-ichi Fuchida, Akira Okano, Masashi Okamoto, Naoya Ochiai, Chihiro Shimazaki

Published in: International Journal of Hematology | Issue 3/2005

Login to get access
Metadata
Title
Plasmacytoma of the Urinary Bladder in a Renal Transplant Recipient
Authors
Ryoichi Takahashi
Sonoko Nakano
Kyoko Namura
Noriko Yamada
Ryo Uchida
Shin-ichi Fuchida
Akira Okano
Masashi Okamoto
Naoya Ochiai
Chihiro Shimazaki
Publication date
01-04-2005
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 3/2005
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.04148

Other articles of this Issue 3/2005

International Journal of Hematology 3/2005 Go to the issue

Case Report

Successful Treatment with Imatinib Mesylate in a Case of Minor BCR-ABL-Positive Acute Myelogenous Leukemia

OriginalPaper

Long-term Results of a Multicenter Randomized, Comparative Trial of Modified CHOP versus THP-COP versus THP-COPE Regimens in Elderly Patients with Non-Hodgkin’s Lymphoma

OriginalPaper

Tacrolimus-Related Encephalopathy following Allogeneic Stem Cell Transplantation in Children

OriginalPaper

Antigen Recognition and Presentation by Dendritic Cells

Letter

Trisomy 22 as the Sole Karyotypic Abnormality in Myelodysplastic Syndrome

Review Article

In Vivo Platelet Production from Mature Megakaryocytes: Does Platelet Release Occur via Proplatelets?
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits